Network Insights Methodology Whitepaper Get Access

Novartis

ORG Health Care / Pharmaceuticals Momentum 10.5ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$57.9B revenue (Basel) manufactures prescription drugs, oncology treatments, and specialty pharmaceuticals across 140+ countries. Recent partnerships with Nucor and US Forged Rings signal domestic manufacturing expansion amid supply chain reshoring trends.

Novartis partnering with Nucor and US Forged Rings on domestic manufacturing investments; expanding US industrial footprint across healthcare and industrials sectors.
0.31
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
10.5
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
26
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Novartis is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Merck China FDA AstraZeneca PlocamiumAI Anthropic European Union United States North Carolina CEO Eli Lilly Texas United Kingdom DOD Senator
Watch This Entity
PSI Intelligence
30-Day Trend
2026-07-14 2026-08-13 27 0 Degree Mentions
Signal Decomposition
Attention Cascade
3.333
Narrative Drift
0.000
Spectral Shift
271.603
Sentiment-Momentum Divergence
0.000
Source Concentration
0.802
Signal
Novartis is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #5 of 73 in Health Care — above 94% of sector peers. PSI up 0.35 from yesterday (-0.00 -> 0.34).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
5 of 73
Sector Rank
+1.19
Peer Z-Score
94%
Sector Percentile
Network Analysis
26 Degree Centrality
Ego Network (top connections)
Merck (weight 148.0)China (weight 14.0)FDA (weight 12.0)AstraZeneca (weight 8.0)PlocamiumAI (weight 8.0)Anthropic (weight 8.0)European Union (weight 7.0)United States (weight 7.0) MerckChinaFDAAstraZenecaPlocamiumAIAnthropicEuropean UnionUnited States Novartis (degree 26) Novartis
Centrality History
2026-07-14 2026-08-13 27 0 Degree Mentions
EntityWeight StatusFirst Seen
Merck 148 NEW
China 14 NEW
FDA 12 NEW
AstraZeneca 8 NEW
PlocamiumAI 8 NEW
Anthropic 8 NEW
European Union 7 NEW
United States 7 NEW
North Carolina 6 NEW
CEO 4 NEW
Eli Lilly 3 NEW
Texas 3 NEW
United Kingdom 3 NEW
DOD 3 NEW
Senator 2 NEW
Germany 2 NEW
Boeing 2 NEW
Intel 2 NEW
SEC 2 NEW
TSMC 2 NEW
European Commission 2 NEW
New Jersey 2 NEW
South Korea 2 NEW
Airbus 2 NEW
Asia 2 NEW
Switzerland 1 NEW
Article Coverage (1)
DateLaneTitle
2026-08-11 Healthcare M&A Trump Orders Review That Could Reshape Childhood Vaccine Schedule

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-08-13 ← Intelligence Network